Get the Stockscreener App
101.32
0.80%
0.80
After Hours:
101.32
Lantheus Holdings Inc stock is traded at $101.32, with a volume of 416.38K.
It is up +0.80% in the last 24 hours and down -1.40% over the past month.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
See More
Previous Close:
$100.52
Open:
$100
24h Volume:
416.38K
Relative Volume:
0.48
Market Cap:
$7.01B
Revenue:
$1.50B
Net Income/Loss:
$427.61M
P/E Ratio:
16.86
EPS:
6.01
Net Cash Flow:
$423.98M
1W Performance:
+2.85%
1M Performance:
-1.40%
6M Performance:
-12.39%
1Y Performance:
+64.80%
1-Day Range:
$97.43
$101.72
1-Week Range:
$96.00
$104.00
52-Week Range:
$61.47
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Name
Lantheus Holdings Inc
Sector
Phone
978 671-8001
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Compare LNTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
101.32 | 7.01B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
148.66 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Goldman | Buy |
| Sep-03-24 | Initiated | Redburn Atlantic | Buy |
| Jul-10-24 | Reiterated | JMP Securities | Mkt Outperform |
| Dec-18-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-04-23 | Initiated | TD Cowen | Outperform |
| Sep-29-23 | Initiated | William Blair | Outperform |
| Mar-08-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-30-22 | Initiated | SVB Leerink | Outperform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| May-09-22 | Initiated | B. Riley Securities | Buy |
| Apr-13-22 | Initiated | Truist | Buy |
| Feb-01-21 | Initiated | SVB Leerink | Outperform |
| Jun-29-20 | Resumed | Jefferies | Buy |
| Aug-16-19 | Upgrade | CJS Securities | Market Perform → Market Outperform |
| Nov-02-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Nov-08-16 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-23-16 | Resumed | Credit Suisse | Neutral |
| Feb-24-16 | Reiterated | RBC Capital Mkts | Outperform |
| Dec-11-15 | Downgrade | Credit Suisse | Outperform → Neutral |
| Sep-30-15 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jul-20-15 | Initiated | Credit Suisse | Outperform |
| Jul-20-15 | Initiated | Jefferies | Buy |
| Jul-20-15 | Initiated | RBC Capital Mkts | Outperform |
| Jul-20-15 | Initiated | Robert W. Baird | Outperform |
| Jul-20-15 | Initiated | Wells Fargo | Outperform |
View All
Lantheus Holdings Inc Stock (LNTH) Latest News
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights By Investing.com - Investing.com India
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - The Globe and Mail
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights - Investing.com India
Lantheus Closes Evergreen Theragnostics Acquisition - MarketScreener
Lantheus Completes Acquisition of Evergreen Theragnostics - TipRanks
Lantheus completes acquisition of Evergreen Theragnostics - TipRanks
Lantheus bolsters radiopharmaceutical portfolio with acquisition - Investing.com
Major Radiopharmaceutical Deal: Lantheus Acquires Evergreen, Gains Revenue-Generating Assets - Stock Titan
How To Trade (LNTH) - news.stocktradersdaily.com
Lobbying Update: $420,000 of LANTHEUS HOLDINGS INC. lobbying was just disclosed - Nasdaq
Q4 Earnings Review: Medical Devices & SuppliesImaging, Diagnostics Stocks Led by GE HealthCare (NASDAQ:GEHC) - The Globe and Mail
CytoSite Bio Announces Agreement with Lantheus for Granzyme B Targeted PET Imaging Radiotracer for Immunotherapy Assessment - Yahoo Finance
Returns On Capital Are A Standout For Lantheus Holdings (NASDAQ:LNTH) - Yahoo Finance
Lantheus Holdings: One Blockbuster, Evolving Pipeline (NASDAQ:LNTH) - Seeking Alpha
Are Strong Financial Prospects The Force That Is Driving The Momentum In Lantheus Holdings, Inc.'s NASDAQ:LNTH) Stock? - simplywall.st
How to Take Advantage of moves in (LNTH) - Stock Traders Daily
Insider Sell: Marshall Robert J. Jr. Sells 10,000 Shares of Lant - GuruFocus.com
Lantheus price target lowered to $122 from $127 at B. Riley - TipRanks
B. Riley Cuts Price Target on Lantheus Holdings to $122 From $127, Keeps Buy Rating - Marketscreener.com
Lantheus Holdings CFO Marshall sells $1.01 million in stock By Investing.com - Investing.com Australia
Lantheus Holdings CFO Marshall sells $1.01 million in stock - Investing.com
Commit To Buy Lantheus Holdings At $75, Earn 14.4% Using Options - Nasdaq
Is Lantheus Holdings, Inc. (LNTH) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey
Jones Financial Companies Lllp Acquires 1,182 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Lantheus Holdings’ SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa
10 Best Healthcare Stocks For Long-Term Investment - Insider Monkey
Lantheus Holdings’ SWOT analysis: stock poised for growth amid challenges - Investing.com India
Charles Schwab Investment Management Inc. Reduces Holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Lantheus at Leerink Global Healthcare Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Lantheus at Leerink Global Healthcare Conference: Strategic Growth Plans - Investing.com
Earnings To Watch: Lantheus Holdings Inc (LNTH) Reports Q4 2024 Result - GuruFocus.com
Trading (LNTH) With Integrated Risk Controls - Stock Traders Daily
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & SuppliesImaging, Diagnostics Stocks - Yahoo Finance
Lantheus Holdings, Inc. (NASDAQ:LNTH) Receives $132.86 Consensus Price Target from Analysts - Defense World
Lantheus Holdings president Paul Blanchfield sells $204,232 in stock - Investing.com Australia
Lantheus Holdings president Paul Blanchfield sells $204,232 in stock By Investing.com - Investing.com UK
Lantheus Holdings: Pylarify Makes Bull Case Despite Looming Patent Expiry (LNTH) - Seeking Alpha
Why Lantheus Holdings Stock Got Thrashed on Tuesday - AOL
Lantheus at TD Cowen Conference: Strategic Growth in Radiopharmaceuticals By Investing.com - Investing.com Canada
Lantheus at TD Cowen Conference: Strategic Growth in Radiopharmaceuticals - Investing.com
Lantheus Holdings director sells $5 million in stock - Investing.com
Lantheus Holdings' (NASDAQ:LNTH) Soft Earnings Are Actually Better Than They Appear - Yahoo Finance
IFP Advisors Inc Sells 9,598 Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) - Defense World
Why Lantheus Shares Are Facing a Downturn - TipRanks
Lantheus Holdings (NasdaqGM:LNTH) Sees 19% Surge Following 2024 Earnings US$1.534 Billion Sales Increase - Yahoo Finance
Lantheus Holdings Inc Stock (LNTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lantheus Holdings Inc Stock (LNTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Heino Mary Anne | Director |
Mar 13 '25 |
Sale |
100.13 |
2 |
200 |
8,618 |
| Heino Mary Anne | Director |
Jun 07 '24 |
Sale |
81.26 |
1 |
81 |
37,719 |
1.29%
0.66%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):